Metraipolis › archive › dc_a661d83ab418

Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by… — Europe PMC PMID:41164972

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41164972
DOI
10.1002/cam4.71177
License (as archived)
solo-consultazione
Archived
2026-11-08T20:52:36.742Z
SHA-256 of the archived text
60f16fd8c4a12f738f4b735ba59e647ac4a47d1e41de3e2b423780fce567373e
Stable URL of this page
https://metraipolis.com/documento/dc_a661d83ab418

How to cite

Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by… — Europe PMC PMID:41164972 — Europe PMC (en), https://europepmc.org/article/MED/41164972 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a661d83ab418 (Metraipolis archive dc_a661d83ab418, sha256 60f16fd8c4a12f738f4b735ba59e647ac4a47d1e41de3e2b423780fce567373e)
BibTeX
@misc{dca661d83ab418,
  title = {Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by… — Europe PMC PMID:41164972},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41164972},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a661d83ab418; sha256 60f16fd8c4a12f738f4b735ba59e647ac4a47d1e41de3e2b423780fce567373e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41164972. Agents can read the archived copy with the MCP tool read_document.